May 29, 2021
1 min read

UK approves single-dose J&J Covid vaccine

This is the fourth Covid-19 vaccine to be authorised by the UK’s independent regulator and is the first to be approved for protection against the Covid-19 with a single-dose, reports Asian Lite Newsdesk

The Johnson & Johnson single-dose Covid-19 vaccine has been approved in the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) said on Friday.

This is the fourth Covid-19 vaccine to be authorised by the UK’s independent regulator and is the first to be approved for protection against the Covid-19 with a single dose.

“We have undertaken a thorough review of the conditional marketing authorisation application submitted by Janssen (part of Johnson & Johnson), including the information on quality, safety and effectiveness. I am pleased to confirm today that this authorisation has been granted,” MHRA Chief Executive June Raine said in a statement.

single-dose
A man wearing a face mask cycles past the Francis Crick Institute Vaccination Centre in London,UK , Britain, March 18, 2021. (Xinhua/Han Yan/IANS)

“This is encouraging news for the public and the healthcare sector. We now have four safe and effective vaccines approved to help protect us from Covid-19,” Raine added.

The MHRA also obtained independent scientific advice from the Commission on Human Medicines (CHM) and its Covid-19 Expert Working Group.

The MHRA approval authorises the use of the vaccine in people aged 18 and over.

The decision on whether to use the vaccine in pregnant or breast-feeding women should be made in consultation with a healthcare professional after considering the benefits and risks, the statement reads.

The MHRA is thought to have held back from early approval of the vaccine after concerns were raised in the US about a link to extremely rare blood clots, similar to those seen in few people having the Oxford-AstraZeneca jab. Earlier, Health Secretary Matt Hancock said that that almost half, and possibly three-quarters, of all new coronavirus cases in the country are of the B.1.617 variant.

Addressing a press conference at Downing Street, Hancock said: “We always expected cases to rise as we rolled out the roadmap, we must remain vigilant.”

Previous Story

A window of opportunity for India in Afghanistan

Next Story

Jaishankar, Blinken, affirm strong India-US ties

Latest from -Top News

£13.9 billion of R&D fund to boost innovation, jobs

Funding outlined to support transformational R&D in areas like life sciences, green energy, engineering and beyond More UK innovators like those developing treatment-transforming dementia tests or building world-leading testing facilities to power

OPEC+ accelerates oil output hikes

Despite the production boost, the group emphasised that future adjustments remain flexible and could be paused or reversed depending on market conditions. Eight OPEC+ nations have unexpectedly decided to accelerate their oil

ATM 2025 set for record turnout

Registrations have surged by an impressive 104% compared to the same period last year, underscoring ATM’s growing influence in the international travel trade landscape. With just three weeks to go until the

UAE team aids Myanmar relief efforts

The search and rescue operation will take place across six locations in Myanmar, with teams working in rotating morning and evening shifts to expedite response efforts and reach as many affected areas

Trump due in Saudi, UAE amid new tariffs

The GCC bloc, which includes the UAE, Saudi Arabia, Oman, Kuwait, Qatar, and Bahrain, has been hit with a 10% tariff, placing them among the lower-tiered rates US President Donald Trump has
Go toTop

Don't Miss

UK-EU talks to continue on Northern Ireland protocol

The spokesperson said the talks had been constructive so far,

BRITAIN FACES STRIKE CHAOS

The National Education Union (NEU), which is the biggest teaching